Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39

FDA recall notice · announced January 28, 2026 · Cipla

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39

Reason for recall

Failed PH Specifications

Notes

Distribution: Nationwide in the USA
Lot/code information: Batch XHBG; Exp. 08/31/2027
Quantity: 92,376 tubes
Status: Ongoing
Products in this recall event:
- Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39 (D-0291-2026)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.